439 related articles for article (PubMed ID: 34854906)
21. Statin but not aspirin treatment is associated with reduced cardiovascular risk in patients with diabetes without obstructive coronary artery disease: a cohort study from the Western Denmark Heart Registry.
Olesen KKW; Heide-Jørgensen U; Thim T; Thomsen RW; Bøtker HE; Sørensen HT; Maeng M
Eur Heart J Cardiovasc Pharmacother; 2022 Aug; 8(5):434-441. PubMed ID: 33989394
[TBL] [Abstract][Full Text] [Related]
22. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
Lee J; Lee S
Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928
[TBL] [Abstract][Full Text] [Related]
23. Effect of Statin Therapy on Mortality in Older Adults Hospitalized with Coronary Artery Disease: A Propensity-Adjusted Analysis.
Rothschild DP; Novak E; Rich MW
J Am Geriatr Soc; 2016 Jul; 64(7):1475-9. PubMed ID: 27295083
[TBL] [Abstract][Full Text] [Related]
24. Use of statins for the prevention of cardiovascular disease in 41 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data.
Marcus ME; Manne-Goehler J; Theilmann M; Farzadfar F; Moghaddam SS; Keykhaei M; Hajebi A; Tschida S; Lemp JM; Aryal KK; Dunn M; Houehanou C; Bahendeka S; Rohloff P; Atun R; Bärnighausen TW; Geldsetzer P; Ramirez-Zea M; Chopra V; Heisler M; Davies JI; Huffman MD; Vollmer S; Flood D
Lancet Glob Health; 2022 Mar; 10(3):e369-e379. PubMed ID: 35180420
[TBL] [Abstract][Full Text] [Related]
25. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Chou R; Cantor A; Dana T; Wagner J; Ahmed AY; Fu R; Ferencik M
JAMA; 2022 Aug; 328(8):754-771. PubMed ID: 35997724
[TBL] [Abstract][Full Text] [Related]
26. Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database.
Vinogradova Y; Coupland C; Brindle P; Hippisley-Cox J
BMJ; 2016 Jun; 353():i3305. PubMed ID: 27353261
[TBL] [Abstract][Full Text] [Related]
27. Early statin initiation and outcomes in patients with acute coronary syndromes.
Newby LK; Kristinsson A; Bhapkar MV; Aylward PE; Dimas AP; Klein WW; McGuire DK; Moliterno DJ; Verheugt FW; Weaver WD; Califf RM;
JAMA; 2002 Jun; 287(23):3087-95. PubMed ID: 12069671
[TBL] [Abstract][Full Text] [Related]
28. Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease.
Rodriguez F; Maron DJ; Knowles JW; Virani SS; Lin S; Heidenreich PA
JAMA Cardiol; 2017 Jan; 2(1):47-54. PubMed ID: 27829091
[TBL] [Abstract][Full Text] [Related]
29. Association Between Achieved Low-Density Lipoprotein Levels and Major Adverse Cardiac Events in Patients With Stable Ischemic Heart Disease Taking Statin Treatment.
Leibowitz M; Karpati T; Cohen-Stavi CJ; Feldman BS; Hoshen M; Bitterman H; Suissa S; Balicer RD
JAMA Intern Med; 2016 Aug; 176(8):1105-13. PubMed ID: 27322095
[TBL] [Abstract][Full Text] [Related]
30. Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies.
Awad K; Mohammed M; Zaki MM; Abushouk AI; Lip GYH; Blaha MJ; Lavie CJ; Toth PP; Jukema JW; Sattar N; Banach M;
BMC Med; 2021 Jun; 19(1):139. PubMed ID: 34154589
[TBL] [Abstract][Full Text] [Related]
31. Withdrawal of statins increases event rates in patients with acute coronary syndromes.
Heeschen C; Hamm CW; Laufs U; Snapinn S; Böhm M; White HD;
Circulation; 2002 Mar; 105(12):1446-52. PubMed ID: 11914253
[TBL] [Abstract][Full Text] [Related]
32. Utilization of Statins Beyond the Initial Period After Stroke and 1-Year Risk of Recurrent Stroke.
Lee M; Saver JL; Wu YL; Tang SC; Lee JD; Rao NM; Wang HH; Jeng JS; Lee TH; Chen PC; Ovbiagele B
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28768645
[TBL] [Abstract][Full Text] [Related]
33. Statins for Prevention of Cardiovascular Events in a Low-Risk Population With Low Ankle Brachial Index.
Ramos R; García-Gil M; Comas-Cufí M; Quesada M; Marrugat J; Elosua R; Sala J; Grau M; Martí R; Ponjoan A; Alves-Cabratosa L; Blanch J; Bolíbar B
J Am Coll Cardiol; 2016 Feb; 67(6):630-640. PubMed ID: 26868687
[TBL] [Abstract][Full Text] [Related]
34. Statin use in the secondary prevention of coronary heart disease in primary care: cohort study and comparison of inclusion and outcome with patients in randomised trials.
Wei L; Ebrahim S; Bartlett C; Davey PD; Sullivan FM; MacDonald TM
BMJ; 2005 Apr; 330(7495):821. PubMed ID: 15790616
[TBL] [Abstract][Full Text] [Related]
35. Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial.
Kutner JS; Blatchford PJ; Taylor DH; Ritchie CS; Bull JH; Fairclough DL; Hanson LC; LeBlanc TW; Samsa GP; Wolf S; Aziz NM; Currow DC; Ferrell B; Wagner-Johnston N; Zafar SY; Cleary JF; Dev S; Goode PS; Kamal AH; Kassner C; Kvale EA; McCallum JG; Ogunseitan AB; Pantilat SZ; Portenoy RK; Prince-Paul M; Sloan JA; Swetz KM; Von Gunten CF; Abernethy AP
JAMA Intern Med; 2015 May; 175(5):691-700. PubMed ID: 25798575
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Time to Benefit of Statins for the Primary Prevention of Cardiovascular Events in Adults Aged 50 to 75 Years: A Meta-analysis.
Yourman LC; Cenzer IS; Boscardin WJ; Nguyen BT; Smith AK; Schonberg MA; Schoenborn NL; Widera EW; Orkaby A; Rodriguez A; Lee SJ
JAMA Intern Med; 2021 Feb; 181(2):179-185. PubMed ID: 33196766
[TBL] [Abstract][Full Text] [Related]
37. Association Between Statin Use and Cardiovascular Events After Carotid Artery Revascularization.
Hussain MA; Saposnik G; Raju S; Salata K; Mamdani M; Tu JV; Bhatt DL; Verma S; Al-Omran M
J Am Heart Assoc; 2018 Aug; 7(16):e009745. PubMed ID: 30369318
[TBL] [Abstract][Full Text] [Related]
38. Effect of statin use for the primary prevention of cardiovascular disease among older adults: a cautionary tale concerning target trials emulation.
Mésidor M; Sirois C; Guertin JR; Schnitzer ME; Candas B; Blais C; Cossette B; Poirier P; Brophy JM; Lix L; Tadrous M; Diop A; Hamel D; Talbot D
J Clin Epidemiol; 2024 Apr; 168():111284. PubMed ID: 38367659
[TBL] [Abstract][Full Text] [Related]
39. Association between Statins Prescribed for Primary and Secondary Prevention and Major Adverse Cardiac Events among Older Adults with Frailty: A Systematic Review.
Hale M; Zaman H; Mehdizadeh D; Todd O; Callaghan H; Gale CP; Clegg A
Drugs Aging; 2020 Nov; 37(11):787-799. PubMed ID: 32929609
[TBL] [Abstract][Full Text] [Related]
40. Population-wide cohort study of statin use for the secondary cardiovascular disease prevention in Scotland in 2009-2017.
Thalmann I; Preiss D; Schlackow I; Gray A; Mihaylova B
Heart; 2023 Feb; 109(5):388-395. PubMed ID: 36192149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
